BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28625647)

  • 1. Quantification of growth patterns of screen-detected lung cancers: The NELSON study.
    Heuvelmans MA; Vliegenthart R; de Koning HJ; Groen HJM; van Putten MJAM; Yousaf-Khan U; Weenink C; Nackaerts K; de Jong PA; Oudkerk M
    Lung Cancer; 2017 Jun; 108():48-54. PubMed ID: 28625647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry.
    Shin KE; Lee KS; Yi CA; Chung MJ; Shin MH; Choi YH
    Respirology; 2014 Aug; 19(6):921-8. PubMed ID: 24934105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
    Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
    Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
    Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
    Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
    AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
    Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
    Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy.
    de Hoop B; van Ginneken B; Gietema H; Prokop M
    Radiology; 2012 Nov; 265(2):611-6. PubMed ID: 22929331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals.
    Heuvelmans MA; Oudkerk M; de Bock GH; de Koning HJ; Xie X; van Ooijen PM; Greuter MJ; de Jong PA; Groen HJ; Vliegenthart R
    Eur Radiol; 2013 Jul; 23(7):1836-45. PubMed ID: 23508275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial.
    Walter JE; Heuvelmans MA; Yousaf-Khan U; Dorrius MD; Thunnissen E; Schermann A; Groen HJM; van der Aalst CM; Nackaerts K; Vliegenthart R; de Koning HJ; Oudkerk M
    J Thorac Oncol; 2018 Sep; 13(9):1410-1414. PubMed ID: 29775805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodule management protocol of the NELSON randomised lung cancer screening trial.
    Xu DM; Gietema H; de Koning H; Vernhout R; Nackaerts K; Prokop M; Weenink C; Lammers JW; Groen H; Oudkerk M; van Klaveren R
    Lung Cancer; 2006 Nov; 54(2):177-84. PubMed ID: 16989922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
    Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
    Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
    Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
    Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
    Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up.
    Xu DM; van der Zaag-Loonen HJ; Oudkerk M; Wang Y; Vliegenthart R; Scholten ET; Verschakelen J; Prokop M; de Koning HJ; van Klaveren RJ
    Radiology; 2009 Jan; 250(1):264-72. PubMed ID: 18984780
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Mets OM; Chung K; Zanen P; Scholten ET; Veldhuis WB; van Ginneken B; Prokop M; Schaefer-Prokop CM; de Jong PA
    Eur Respir J; 2018 Apr; 51(4):. PubMed ID: 29650547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and work-up of small to intermediate-sized pulmonary nodules in a Chinese dedicated cancer hospital.
    Cui X; Han D; Heuvelmans MA; Du Y; Zhao Y; Zhang L; Groen HJM; de Bock GH; Dorrius MD; Oudkerk M; Vliegenthart R; Ye Z
    Cancer Biol Med; 2020 Feb; 17(1):199-207. PubMed ID: 32296586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.